
    
      Study Population:

      Post-surgical (thoracic, cardiac or abdominal surgery) non-mechanically ventilated patients
      with significant atelectasis as documented by chest x-ray results.

      Duration of treatment:

      Duration of treatment with The MetaNebÂ® System will be a minimum of 48 hours, or until the
      subject is discharged from the hospital (if discharge is earlier). Enrolled subjects will
      remain in the study through Day 4 or until the subject is discharged from the hospital,
      whichever occurs sooner.
    
  